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Abstract
Tuberculosis exerts a tremendous burden on global health, with ,9 million new infections and ,2 million deaths annually.
The Mycobacterium tuberculosis complex (MTC) was initially regarded as a highly homogeneous population; however, recent
data suggest the causative agents of tuberculosis are more genetically and functionally diverse than appreciated previously.
The impact of this natural variation on the virulence and clinical manifestations of the pathogen remains largely unknown.
This report examines the effect of genetic diversity among MTC clinical isolates on global gene expression and survival
within macrophages. We discovered lineage-specific transcription patterns in vitro and distinct intracellular growth profiles
associated with specific responses to host-derived environmental cues. Strain comparisons also facilitated delineation of a
core intracellular transcriptome, including genes with highly conserved regulation across the global panel of clinical isolates.
This study affords new insights into the genetic information that M. tuberculosis has conserved under selective pressure
during its long-term interactions with its human host.
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Introduction
Mycobacterium tuberculosis represents a unique opportunity to
explore the impact of evolution and genetic diversity on bacterial
host adaptation and pathogenesis. Tuberculosis is an ancient
disease, with evidence that the causative agent M. tuberculosis has
been co-evolving with its human host since mankind emerged
from Africa 50,000 years ago [1], [2]. Despite intense efforts, the
disease remains a major burden on global health and a strong
selective pressure on human evolution [3]. M. tuberculosis is the
most prominent member of the Mycobacterium tuberculosis complex
(MTC), comprised of seven closely related species with distinct
host tropisms including the human pathogens M. africanum and M.
canettii and the animal adapted species M. bovis (bovine), M. caprae
(goats), M. pinnipedii (seals), and M. microti (rodents). Members of
the MTC are considered genetically monomorphic with a high
level of genomic sequence similarity (.99.95%), limited horizontal
gene transfer, and a clonal population structure [4], [5]. This
apparent homogeneity led to the assumption that genetic diversity
among MTC strains would not be of clinical significance.
However, recent data based on molecular genotyping methods
(i.e. IS6110 RFLP, spoligotyping, MIRU-VNTR typing) revealed
a highly diverse population structure with at least six major
geographically-associated lineages that can be further subdivided
into well-defined genotypes [1], [2]. Based on multilocus sequence
analysis of 89 genes in 108 strains, Hershberg et al. conservatively
estimated that an average pair of MTC strains would have ,300
functional differences due to SNPs alone [1]. Thus, it is becoming
apparent that the genetic diversity of the MTC has been
underestimated.
There is mounting evidence that the genetic variability among
clinical isolates may have dramatic consequences on the outcome
of infections. For example, studies in vitro [6], [7], [8], in animal
models [9], [10], [11], [12], [13], and human epidemiology studies
[14] have demonstrated strain-dependent variation in key aspects
of virulence such as stress survival, transmission, pathology, and
lethality. It is also believed that the genetic diversity of the MTC
contributes to the wide spectrum of TB clinical presentations,
including acute primary TB (localized or disseminated), latent
disease and reactivation [15], [16]. However, the molecular
mechanisms for such variations in M. tuberculosis pathogenesis and
host adaptation have been identified in only a few cases. In one
example, the hypervirulence of some Beijing strains has been
linked to the production of immune modulatory phenolic
glycolipid (PGL), whereas a 7bp deletion in the pks 15/1 gene
disables PGL synthesis in many isolates [13], [17], [18]. Genetic
variation may also lead to altered metabolism and gene expression
pathways important for MTC pathogenesis [19], [20], [21].
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within the phagosome of professional phagocytes and persist
within pulmonary granulomas for decades. This most intimate of
inter-species associations has led to the evolution of strategies to
resist antimicrobial effectors and subvert the immune response.
Information on the ‘‘common’’ and ‘‘variable’’ responses of
clinical isolates of different phylogenetic lineages to host
macrophages is crucial for identification of microbial factors
required for intracellular survival or involved in the adaptation to
specific hosts. However, studies analyzing gene expression and
virulence of MTC in infection models have largely been restricted
to a limited number of individual strains [22], [23].
This study details a systematic approach to define the degree to
which diversity, hard-wired into the bacterial genome, translates
into functional phenotypes reflected in expression profiling and
bacterial survival within macrophages. We investigated a panel of
17 strains that represent the global phylogeographic diversity of
MTC: two reference strains H37Rv and CDC1551 and 3 clinical
isolates each from 5 distinct genotypes. The varied survival
characteristics of the clinical isolates within macrophages, in
addition to the heterogeneity of the in vitro and intracellular
transcriptome profiles are evidence of the powerful effect genetic
variation exerts on global gene expression and host interactions.
Our approach of linking well-characterized genotypes to tran-
scriptional responses induced by conditions relevant to infection (in
vitro, versus resting and activated murine macrophages) is a crucial
step toward understanding the functional evolution of MTC and
the varied pathologies of tuberculosis.
Results
Evolution of MTC clinical isolates evident in basal in vitro
transcriptome
To determine the functional impact of the natural genetic
diversity of pathogenic mycobacteria, we first studied the growth
and gene expression of MTC clinical isolates from five global
phylogeographical lineages in liquid culture (Figure 1A, Table 1,
Supplementary Figure S1). The growth kinetics of most strains in
rich medium, especially members of the Beijing, EAI, and West
African 2 genotypes, were not significantly different from the
reference strains CDC1551 and H37Rv. However, clinical isolates
of the Haarlem and Uganda genotypes exhibited slower growth
rates in vitro (Supplementary Figure S2 and S7A). Microarray
profiling of log phase bacteria (OD,0.6) yielded expression
patterns that mirror the phylogenetic relationship of strains as
defined by molecular typing methods (Figure 1B). Condition tree
analysis of in vitro transcriptome data segregated strains into two
main branches consistent with the recently described classification
of ‘‘modern’’ clade 1 and ‘‘ancient’’ clade 2 strains (Figure 1B) [2].
A total of 156 genes exhibited clade specific profiles (Supplemen-
tary Figure S3, Supplementary Tables S1 and S2), highlighting the
functional divergence of these two MTC lineages. Gene clusters
with higher expression in clade 1 (i.e. narGHJI, nitrate reductase
operon) or clade 2 (i.e. mce4 locus, implicated in cholesterol
utilization [24]), confirmed by qRT-PCR analysis of narG
(Supplementary Figure S10A) and mce4C (Supplementary Figure
S9A) could have a significant impact on the ‘‘success’’ of these
strains across their human host populations.
We identified 364 genes (,10% of all genes) with significant
expression differences (p,0.01) between strains of different
genotypes in at least one pair-wise comparison (Figure 2A). Our
analyses delineated genotype-specific signatures (Figure 2B) like
the virS-mym operon (Rv3082c-3089) dysegulated in all EAI strains
and the dosRS two-component regulator (Rv3132c-3133c) overex-
pressed in all Beijing strains (Figure 2B). Semi-quantitative qRT-
PCR verified the ,10-fold higher basal expression level of dosR in
Beijing isolates (Supplementary Figure S8 and S9B), the elevated
transcription of virS (3-fold) and concomitant repression (,50-fold)
of Rv3083 in EAI strains (Supplementary Figure S8 and S9C).
Additionally, we identified profiles shared between genotypes such
as the moa operon (moaE3, moaC3, gphA, MT3427, MT3427.1)
hyper-expressed in Beijing and Haarlem strains. Similarly,
transcripts of the Rv3612c-3616c operon, involved in secretion
of the virulence factor ESAT-6, were more abundant in the
Haarlem and Uganda genotypes while exhibiting diminished
expression in EAI strain 1797/03 (Figure 2C). Subsequent 1-way
ANOVA analysis (p,0.01) identified a total of 195 genes with
strain-specific gene expression profiles (Supplementary Figure S4).
The elevated expression of the fabG1-inhA-hemZ operon (Rv1483-
1485) in a single West African 2 strain, for example, highlights the
potential for genetic variation to alter a drug target (InhA) involved
in cell wall biosynthesis (Figure 2C). In fact, subsequent analysis of
strain 10514/01 revealed a previously described CRT substitu-
tion at position 215 upstream of this operon [25] accompanied by
isoniazid resistance (data not shown). The negligible detection of
eleven IS6110 related genes in strain 1797/03, defined as a
subgroup of the EAI genotype by unique IS6110 RFLP
fingerprinting, illustrates the potential to identify possible deletions
among clinical isolates based on gene expression data (Figure 2C,
Supplementary Figure S1).
This remarkable degree of diversity in the basal transcriptome
of MTC clinical isolates in vitro provides compelling evidence that
genomic variation among strains results in a greater functional
impact than appreciated previously.
Variable survival of MTC clinical isolates in murine
macrophages
To test the hypothesis that the disparate patterns of gene
expression described above would influence the ability of MTC
Author Summary
Genetic polymorphisms among bacterial pathogens are
exploited by epidemiologists to monitor disease outbreaks
and transmission of specific strains. Genetic variations
occur under selective pressures imposed by the human
host, leading to variation amongst clinical isolates.
Tuberculosis (TB) is an ancient disease caused by
Mycobacterium tuberculosis that still exerts a tremendous
burden on global health. M. tuberculosis was widely
regarded as a homogeneous population with limited
genetic variability. However, data from recent studies
suggest that the functional diversity of this pathogen has
been underestimated. This study features a panel of
isolates spanning the phylogenetic diversity of the M.
tuberculosis complex. Using microarrays, we found that the
genetic diversity of M. tuberculosis strains has significant
impact on global gene expression. The distinct abilities of
strains to survive inside macrophages and alter gene
expression during infection highlight novel strategies of
intracellular adaptation. We also delineated a core
intracellular transcriptome across the panel of strains. This
affords new insights into the genetic information that M.
tuberculosis conserves to remain a successful intracellular
pathogen. Elucidating the functional significance of M.
tuberculosis genetic diversity is important for understand-
ing the diverse outcomes of infection, mechanisms of
pathogenesis, and for the development of effective new
diagnostic and therapeutic tools.
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growth of our panel of 15 clinical isolates and reference strains
CDC1551 and H37Rv in resting and activated murine macro-
phages for 11 days. We found that intracellular growth revealed
clade-, genotype- and strain-specific fitness profiles for survival
within macrophages even more clearly than in vitro growth
(Figure 3, Supplementary Figure S7B–C).
In resting macrophages, intracellular survival of most clade 1
clinical isolates was similar to CDC1551 and H37Rv (Figure 3A–
C, Supplementary Figure S7B). This was not surprising given that
molecular genotyping indicates CDC1551 and H37Rv are related
to the Haarlem and Uganda genotypes, respectively (Figure 1A).
Consistent with Theus et al. [26], we did not observe the previously
reported hypervirulence of Beijing strains in our infection model
[27], [28] (Figure 3C). It is notable that most clade 2 strains
exhibited either an early survival defect (EAI 4850/03, 947/01)
and/or significantly impaired replication in resting macrophages
compared to clade 1 or reference strains (Figure 3D–E,
Supplementary Figure S7B). A single clade 1 isolate within the
Uganda genotype (2169/99) was severely attenuated for intrama-
crophage survival during early stages of infection perhaps linked to
its poor in vitro replication (Figure 3B, Supplementary Figure S2
and S7B). However, overall there was no direct correlation
between in vitro growth rates and intracellular fitness. For example,
EAI and West African 2 isolates were clearly impaired for survival
in resting macrophages compared to Beijing strains, despite similar
replication kinetics in vitro.
Activation of the host macrophages with interferon-g and LPS
accentuated the differences in intracellular growth between clinical
isolates (Figure 3F–J). Note the divergence of CDC1551 and
H37Rv intracellular growth profiles compared to resting macro-
phages (Figure 3A and 3F). Although activated macrophages were
more effective at suppressing mycobacterial growth until day 7, we
did note a late rebound by most MTC isolates after day 7 perhaps
indicating delayed bacterial adaptation or a waning of antimicro-
bial effectors in the activated macrophages. Pair-wise comparisons
between all strains using the Tukey-Kramer HSD test delineated
significant genotype- and strain-dependent intracellular growth
profiles (Supplementary Figure S7C). For example, the Haarlem
genotype proved to be better adapted for phagosome survival than
Beijing, EAI, or West African 2 isolates (Figure 3F, Supplementary
Figure S7C). Contrary to previous reports of enhanced intracel-
lular replication [9], [27], [28], Beijing isolates grew only slightly
better than CDC1551 (Figure 3H). Uganda strain 2169/99
survived but failed to grow in activated macrophages, consistent
with its subpar growth in vitro and in resting macrophages
(Figure 3G). In activated macrophages, the growth profiles of
clade 2 isolates were distinct from Haarlem, Uganda (except
2169/99), and H37Rv (Supplementary Figure S7C). Strains of the
EAI genotype presented a unique profile, experiencing an acute
Figure 1. Genetic and transcriptome diversity of M. tuberculosis complex (MTC) clinical isolates. (A) Radial neighbor-joining tree based on
24 loci MIRU-VNTR and 43 spacer spoligotyping showing the phylogenetic relationship of strains in this study. Three strains each from the 5 distinct
lineages pathogenic to humans plus two sequenced reference strains (H37Rv and CDC1551) were chosen to represent the global diversity of MTC.
The color used to denote each genotype is maintained in all subsequent figures for clarity. (B) Condition tree of MTC clinical isolate transcription
profiles in vitro during log phase growth in 7H9 medium relative to CDC1551 reference strain (three biological replicates). Expression profiles for
genes passing quality filters (flagged as present in 42 of 48 samples) with differential expression in at least one strain (up or down .1.56in at least 1
of 16) were clustered using the Spearman correlation. Each column represents the global transcription profile of a single strain. Genes were clustered
vertically based on the distance measure. Red and blue indicate higher or lower gene expression than CDC1551 control, respectively. Unless
otherwise indicated, the color scale for expression (4-fold up or down) was used for all subsequent figures.
doi:10.1371/journal.ppat.1000988.g001
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day 11. Intriguingly, West African 2 strains (M. africanum) appear
better adapted for growth in activated versus resting macrophages
(compare Figure 3E and 3J).
MTC strains exhibit a highly conserved core intracellular
transcriptome
To determine the effect of natural genomic variation on the
response of MTC isolates to the intracellular niche, we conducted
microarray analysis of intracellular MTC bacilli 24h after infection
of resting and activated murine macrophages. This facilitated
identification of a highly-conserved, core intramacrophage
transcriptome which included 280 genes either universally induced
(168 genes) or repressed (112 genes) in all strains, regardless of
activation state of the host cell (Figure 4A–B, Supplementary
Figure S5, Supplementary Tables S3, S4, S5, S6, S7 and S8). The
induction of genes with roles in hypoxia, oxidative and nitrosative
stress, cell wall remodeling, regulation, and fatty acid metabolism
across the panel of clinical isolates confirms previous studies using
single strains [22], [23] and affirms their association with the
adoption of an intracellular lifestyle (Supplementary Figure S5A,
Supplementary Tables S3, S4 and S5). The 112 universally
repressed genes, in addition to reflecting suppression of growth
and energy metabolism, indicate modulation of cell wall
composition (acpM, kasA, fabD, lipoproteins), lipid and cholesterol
transport (mmpL9, mmpL12, mce1 genes lprK, Rv0167, Rv0170,
Rv0172, Rv0176, and mce4 genes Rv3492c, Rv3493c, Rv3497c)
[29], [30], and transcriptional regulation (sigD, cspA, Rv3676)
(Supplementary Figure S5B, Supplementary Tables S6, S7 and
S8). Approximately 40% (114/280) of the ‘‘universal intracellular
transcriptome’’ that exhibited conserved regulation among clinical
isolates were genes of unknown function. The core intracellular
transcriptome highlights fundamental stress responses, pathways,
and genes involved in intracellular survival that are conserved
across the MTC.
Following the initial encounter of pathogenic mycobacteria with
resting alveolar macrophages, the onset of the adaptive immune
response presents an enhanced ‘‘stress test’’ for MTC. Classical
activation of macrophages by IFN-c constrains bacterial growth by
overriding the block in phagolysosome fusion and upregulating
antimicrobial effectors, such as ROI and RNI [31]. However,
despite controlling the infection, the failure to eradicate MTC
indicates that the pathogen is capable of adapting to or modulating
this environment to survive. To identify transcriptional responses
that correlated with activation status of the macrophage, we used
1-way ANOVA analysis of intracellular array data to identify 719
genes whose expression was significantly influenced by macro-
phage activation (p,0.01) across the panel of strains.
Responses to known phagosome parameters enhanced by
activation, such as nitric oxide production (dosR regulon) and iron
limitation (mycobactin operon), were evident among the 317 genes
with elevated induction in activated macrophages (Figure 4C,
Supplementary Table S10). The conserved induction of certain
transcriptional regulators (i.e. whiB3, cpsA), transporters (i.e.ESX-3),
lipid metabolism enzymes (i.e. desA1, desA2, ppsABCDE), and 109
genes of unknown function in all 15 clinical MTC isolates within
activated macrophages indicates a role for these loci in survival
under immune pressure (Figure 4C, Supplementary Table S9).
Our analyses also delineated 402 genes with higher induction
ratios in resting versus activated macrophages (Figure 4D,
Supplementary Table S10). Many genes, such as rps and rpl genes
encoding ribosomal proteins involved in protein synthesis and
histone-like proteins (lsr2, hns, hupB) also fell into this category
because they were highly repressed in activated macrophages
(Figure 4D). The enhanced expression of iron storage genes bfrA
and bfrB are indicative of the iron-replete environment of the
transferrin-accessible resting phagosome [32]. Interestingly, mark-
ers of the general stress response (grpE, groEL, groEL2, groES) were
induced more highly by MTC strains in resting macrophages. This
would imply that these chaperones are required to sustain growth
because many of the genes that exhibited higher expression in
Table 1. Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study.
species No lineage genotype RD9 TbD1 pks15/1 INH RMP PZA EMB SM
M. tuberculosis 9532/03 Euro-American Haarlem + 22 ss ss s
2336/02 Euro-American Haarlem + 22 ss ss s
4130/02 Euro-American Haarlem + 22 ss ss s
2333/99 Euro-American Uganda + 22 ss ss s
2169/99 Euro-American Uganda + 22 sr ss s
2191/99 Euro-American Uganda + 22 ss ss s
1934/03 East Asian Beijing + 2 + ss ss s
1500/03 East Asian Beijing + 2 + ss ss s
12594/02 East Asian Beijing + 2 + ss ss s
4850/03 Indo Oceanic EAI ++ + ss ss s
1797/03 Indo Oceanic EAI ++ + ss ss s
947/01 Indo Oceanic EAI ++ + ss ss s
M. africanum 10517/01 West-African 2 WA2 2 + 2 ss ss s
5468/02 West-African 2 WA2 2 + 2 ss ss s
10514/02 West-African 2 WA2 2 + 2 rs ss s
Molecular genotyping and drug sensitivity testing of Mycobacterium tuberculosis complex (MTC) clinical isolates investigated in this study. Strain lineages are based on
phylogenetic analysis by Gagneux et al. [86]. TbD1, RD9 and pks15/1 denote the presence or absence of previously reported phylogenetic markers [87], [88]. The Euro-
American strains (Haarlem and Uganda genotypes) contain a 7bp deletion and W. African 2 strains contain a 6bp deletion in pks15/1. Abbreviations: EAI (East African
Indian), WA2 (West African 2), INH (isoniazid), RMP (rifampicin), EMB (ethambutol), PZA (pyrazinamide), SM (streptomycin), s (sensitive), r (resistant).
doi:10.1371/journal.ppat.1000988.t001
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nutrient acquisition consistent with replicating organisms.
Lineage specific transcriptional responses to intracellular
cues
The disparate abilities of MTC clinical isolates to survive and
replicate in macrophages could be attributable to both the
distinct baseline patterns of in vitro gene expression (described
above) and/or to strain-dependent transcriptional adaptation to
phagosome-derived cues. Intracellular transcriptome data, which
were normalized to strain-matched extracellular controls to
minimize the contribution of in vitro gene expression differences,
revealed that MTC clinical isolates also exhibited distinct
responses to environmental cues within the phagosome. Although
the responses were more divergent than observed from in vitro
Figure 2. Identification of genotype- and strain- specific in vitro transcription profiles. (A) Pair-wise comparison of genes with significant
genotype-dependent expression. Includes genes identified by one-way ANOVA of quality-filtered geneset (present in 42 of 48 samples) using Benjamini
and Hochberg False Discovery Rate (p,0.01). The matrix of intragenotype comparisons was generated by Tukey post hoc test. The numbers within red
squares indicate genes with unique expression patterns between the two intersecting genotypes. (B) Gene tree of select virulence-associate
transcriptional regulators with genotype-specific expression signatures. The dosRS two-component regulator, overexpressed in Beijing strains, controls
the expression of ,50 genes in response to multiple signals including nitric oxide, hypoxia, and carbon monoxide and is required for infection in animal
models [20], [36], [70], [80], [81], [82], [83]. VirS is overexpressed in EAI strains with concomitant decreased transcript levels of the mymA operon (Rv3083-
Rv3089). virS and mymA genes play a role in cell wall ultrastructure and are required for growth in activated macrophages and in mouse spleen [52], [53].
(C) Gene tree of select loci exhibiting strain-specific expression and profiles shared across multiple genotypes. Expression ratios indicated by color
gradient are in vitro log phase transcript levels relative to CDC1551 reference strain (see Fig. 1B for color key).
doi:10.1371/journal.ppat.1000988.g002
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macrophage invasion still reflected the phylogenetic relationship
of strains with greater correlation between intragenotypic
(Figure 5A) versus intergenotypic (Figure 5B) profiles. One-way
ANOVA analyses (p,0.01) identified 625 genes with genotype-
specific and 293 genes with strain-specific expression across both
resting and activated macrophage datasets. Similar analysis of
each macrophage state separately revealed 114 and 266 genes
with genotype-specific expression patterns in resting and
activated macrophages, respectively. The failure of M. africanum
(West African 2) strains to induce the phthiocerol dimycocerosate
(PDIM) locus, a complex cell wall lipid unique to mycobacteria,
Figure 3. Long-term survival and growth of MTC clinical isolates in macrophages. Resting (A–E) and IFN-c + LPS activated (F–J) murine
bone-marrow derived macrophages were infected at low MOI (,1:1) with MTC strains. Quantification of viable CFU at day 0,2,4,7, and 11 post-
infection were conducted by lysis of monolayers, serial dilution, and plating on 7H10 medium. Error bars indicate standard error of the mean from
two independent biological replicates each consisting of three technical replicates per strain (total of 6 wells/strain). Growth profiles of reference
strains, H37Rv and CDC1551, are shown in green in all panels. Asterisks in the legend indicate strains determined to exhibit growth profiles
significantly different compared to CDC1551 by ANOVA (*=p,0.05, **=p,0.001). Although EAI strains did not reach p,0.05 when time was
modeled as a continuous variable, modeling time as a nominal variable yielded differences of statistical significance at specific time points, indicated
by asterisks at day 2 and day 4 in (I).
doi:10.1371/journal.ppat.1000988.g003
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PLoS Pathogens | www.plospathogens.org 6 July 2010 | Volume 6 | Issue 7 | e1000988Figure 4. The MTC universal intracellular transcriptome: identification of genes with conserved expression and regulation inside
macrophage phagosome across global panel of MTC clinical isolates. Global gene expression profiles of 17 MTC strains 24h post-infection of
resting and activated macrophages were determined by microarray. Normalized expression ratios for each strain were determined by comparison of
RNA from intracellular bacteria versus control bacteria of the same strain treated identically except for phagocytosis by macrophages. This serves to
identify relative responses to phagosomal cues rather than inherent strain-dependent differences in gene expression. (A–B) Venn diagrams showing
activation-dependent (red=activated, blue=resting) and independent (black) genes with conserved expression patterns across clinical isolates.
‘‘Universal genes’’ were selected based on trending up or down in all strains (up or down .1.2-fold in 15 of 17 strains) and significant induction or
Core and Lineage-Specific Transcriptomes from Mtb
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revealed by this study (Figure 5C, Supplementary Figure S10B).
The unique responses of individual strains (Figure 5D) provided
further evidence of the impact of natural genetic variation on
environmental sensing and phagosome adaptation across the
panel of MTC clinical isolates.
repression in .50% of strains (up or down .1.56in 8 of 17 strains) in each macrophage type. The starting gene list for this analysis included only
genes flagged as present in the majority of samples from both macrophage types. (C) Select genes with higher expression levels in activated versus
resting macrophages conserved across all or most clinical isolates. Represents subset of activation-dependent genes identified by one-way ANOVA
analysis of all intracellular transcription profiles (Benjamini and Hochberg False Discovery Rate p,0.01). (D) Select genes with higher expression in
resting versus activated macrophages. See (C) above for analysis description. Refer to Fig 1B for genotype color bar definition (black box denotes
reference strain CDC1551).
doi:10.1371/journal.ppat.1000988.g004
Figure 5. Lineage-specific transcriptional responses of MTC clinical isolates to macrophage invasion. (A) Intragenotype comparison of
gene expression profiles 24h post-infection of resting macrophages. Scatter plot showing similarity of transcriptome modulation of two M. africanum
(genotype West African 2) strains 10514/01 (x-axis) versus 5468/02 (y-axis). (B) Intergenotype comparison of gene expression profiles 24hr post-
infection of resting macrophages. Scatter plot showing M. africanum, genotype West African 2 strain 10514/01 (x-axis) versus M. tuberculosis Beijing
strain 1934/03 (y-axis). Each spot represents a single gene with expression ratios .1 indicating intracellular induction (red spots) and ,1 indicating
intracellular repression (blue spots). The degree of similarity in the regulation of a gene between two strains is shown by proximity to the middle
diagonal line (ratio=1). Axes show normalized expression ratio relative to strain-matched extracellular control in a log10 scale. The number of genes
with .2-fold differences in intracellular regulation are indicated on the graph. The increased scatter and number of differentially regulated genes
seen in strains of different genotypes (B) reflects the diversity of responses to the vacuole environment observed in strains from genetically diverse
lineages. Gene trees showing examples genotype- (C), and strain- (D) specific gene regulation after 24h infection of activated macrophages. Refer to
Fig 1B for genotype color bar definition (black box denotes reference strain CDC1551).
doi:10.1371/journal.ppat.1000988.g005
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impacted by both absolute transcript levels as well as the
appropriate, temporal regulation of gene expression. In the
previous section, we normalized intracellular array data to
strain-matched extracellular controls to focus on relative responses
to the phagosomal environment rather than inherent strain-
dependent differences. To assess the additive effect of baseline in
vitro differences and phagosomal changes in transcription, we
directly compared transcript levels from intracellular MTC
isolates. Although there are potential caveats this in silico analysis,
such as skewing of values due to normalization of data from
separate hybridizations, the constitutive expression of housekeep-
ing genes (i.e. sigA) and qRT-PCR analyses discussed below
(Supplementary Figure S10) served to validate this approach. This
analysis yielded a robust differentiation of phylogenetic relation-
ships which discriminated between strains, genotypes, and clades
(Supplementary Figure S6). For example, the clade 2-specific
underexpression of the nitrate reductase (narGHJI) and overex-
pression of the mce4 locus (Rv3492c-3501c) (Figure 6A) present
candidate mechanisms for the reduced fitness of these strains for
intramacrophage survival (Figure 3). Closer examination of narG
expression by qRT-PCR revealed that diminished in vitro
expression coupled with lack of induction inside macrophages
both contribute to .10-fold lower transcript levels in West African
2 strains within the phagosome (Supplementary Figure S10A).
This analysis identified 499 and 463 genes from resting and
activated macrophages, respectively, with significant (p,0.01)
genotype-dependent differences in phagosomal transcript levels.
Differences in the expression level of other genes involved in toxin-
antitoxin pairs (Rv0549c-0550c), metabolism (glgC), DNA repair
(nrdF,nrdEIH), and transcriptional regulation (furB, whiB4, Rv0452)
point to additional mechanisms by which natural variation in gene
expression may impact mycobacterial pathogenesis.
To further illustrate the integration of our multilevel array
analysis of MTC clinical isolates, Figure 6B–G depicts a
comprehensive examination of the in vitro, intracellular, and
cumulative transcriptional profiles of two sets of genes implicated
in mycobacterial pathogenesis. The polyketide synthesis loci
mmpL8-papA1-pks2 and pks3-pks4-papA3-mmpL10 are required for
the synthesis of sulfolipid (SL) and di- and poly-acyltrehaloses
(DAT, PAT) respectively [33], [34], [35]. The in vitro under-
expression of SL synthesis genes and the repression of DAT/PAT
gene expression in macrophages in West African 2 strains results in
dramatic cumulative differences in the transcript levels of these
genes when the bacilli are inside phagosomes (Figure 6B–D,
Supplementary Figure S10C). The DosR regulon, induced by the
DosRS two-component regulator in response to hypoxia, carbon
monoxide, and nitrosative stress (nitric oxide), is important for
survival in animal disease models [36]. Despite the constitutive
overexpression of dosRS by Beijing strains in vitro (Figure 6E), the
dosR regulon was induced by phagosome cues in all strains
(Figure 6F), with relative transcript levels of dosR-dependent
effectors actually higher in several non-Beijing vs Beijing isolates
(Figure 6G, Supplementary Figure S10D, E). Our findings argue
that further characterization of MTC clinical isolates is warranted
to understand the interplay between genotype, transcriptional
regulation of gene expression, and virulence associated pheno-
types.
Discussion
The longstanding view of pathogenic mycobacteria as a
homogeneous clonal population with negligible functional genetic
diversity has been challenged by recent molecular genotyping
studies [2] and whole genome sequencing of members of the MTC
[37]. This new appreciation of the significant genetic diversity
among MTC isolates has prompted studies documenting strain-
dependent differences in resistance to in vitro stress [6], [7], [38],
interactions with host cells [8], [26], [27], [39], [40], [41], and
virulence in animal infection models [9], [10], [11], [12], [13],
[42], [43], [44]. Phylogenetic analyses of the MTC have
delineated multiple distinct lineages broadly divided into ‘‘mod-
ern’’ (clade 1) and ‘‘ancient’’ (clade 2) strains, with the latter
including animal pathogens with distinct host tropisms [1], [2],
[45], [46]. Although molecular genotyping provides a robust
framework for understanding evolution and epidemiology of
MTC, the functional impact of genetic diversity remains poorly
characterized. Our microarray data revealed phylogenetically-
constrained patterns of in vitro gene expression including clade-,
genotype-, and strain-specific signatures. The dramatic effect of
natural genetic diversity on transcriptome profiles, brought about
by gene deletion, promoter SNPs, or missense mutations in
regulators or other proteins, has yielded a functionally heteroge-
neous population of pathogenic mycobacteria.
The constitutive dysregulation of loci known to impact
mycobacterial pathogenesis highlights putative mechanisms un-
derlying the spectrum of host interactions and disease outcomes
caused by MTC clinical isolates. For example, clade 2 isolates of
the West African 2 and EAI genotypes showed elevated
transcription of the mce4 locus (Figure 6, Supplementary Figure
S9A). The 11-gene mce4 operon encodes a cholesterol import
system that is dispensable for growth in resting macrophages
during early infection but is essential for growth in interferon-c
activated macrophages in order to maintain persistent infections in
the mouse model [30], [47], [48], [49], [50]. Given the repression
of the cholesterol uptake genes by all strains upon macrophage
infection, perhaps to counter the toxicity associated with utilization
of cholesterol [24], the elevated basal expression of the mce4 locus
could conceivably contribute to the reduced fitness of clade 2
strains in macrophages. Altered expression of virulence regulators
could also profoundly influence mycobacteria-host interactions.
Clinical isolates of the EAI genotype constitutively overexpressed
virS (Figure 2B, Supplementary Figure S8 and S9C), an AraC-
family transcriptional regulator found only in the MTC [51]. VirS
is reportedly required for the expression of the adjacent,
divergently transcribed mymA operon (Rv3083-Rv3089) which
acts to modify mycolic acid components of the cell wall during acid
stress [52], [53]. Disruption of either virS or mymA results in altered
cell wall composition and structure, increased sensitivity to
antibiotics and surface-acting stresses, and attenuation of virulence
in activated macrophages and guinea pigs [52], [53]. In contrast to
Singh et al. [53], our data suggest that VirS represses rather than
activates transcription of the mymA locus. The dramatic repression
of the mymA operon in EAI strains overexpressing virS is likely to
have deleterious effects on virulence-associated phenotypes.
Following establishment of the baseline transcriptomes of the
clinical strains in rich medium, we characterized the transcrip-
tional responses of the bacteria following infection of resting and
activated macrophages in the context of their intracellular growth
profiles. This analysis revealed both common and divergent
responses that paralleled the capacity of MTC isolates to survive
intracellularly, albeit with varying degrees of success. The
common responses constitute a rigorous delineation of the core
transcriptome associated with intracellular survival of Mycobacteria.
Many of the ‘‘themes’’ revealed in the core transcriptome,
consisting of 280 genes with 168 genes induced and 112 genes
repressed in the intracellular environment, validate the findings
reported in earlier studies [22], [23]. The ubiquitous expression
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PLoS Pathogens | www.plospathogens.org 9 July 2010 | Volume 6 | Issue 7 | e1000988Figure 6. The additive effect of strain-specific differences in basal in vitro gene expression and transcriptional responses to
intracellular cues. Microarray data from RNA derived from intracellular MTC 24h post-infection were compared directly following median
normalization. This allows quantitative estimation of cumulative ‘‘absolute’’ intracellular transcript levels resulting from in vitro differences plus
phagosome regulation. (A) Gene tree showing clade-specific intracellular expression levels of putative virulence factors. The narGHJI nitrate reductase
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across a global panel of strains should inform the prioritization of
targets for the development of novel biomarkers, drugs, or
vaccines. This data also suggest that the 45% (75/168) of the
core up-regulated genes with no known function, many of which
are unique to Mycobacteria, warrant further investigation.
In contrast to the common responses, the distinct intrama-
crophage fitness levels and intra-strain diversity of transcription
profiles, especially between clade 1 and clade 2 strains, were clear
indicators of unique lineage-specific adaptation to the phagosome
environment. It is notable that gene expression differences were
evident as early as 24hr post-infection before growth/survival of
strains diverged significantly. The identification of lineage-specific
regulons (both known virulence factors and genes of unknown
function) that correlate with phenotypes relevant to pathogenesis
(i.e. survival in macrophages) provides a powerful approach for
discovery of novel strategies of host adaptation and virulence.
Differential regulation of virulence factors by M. africanum, the
most phylogenetically distant genotype in this study, may provide
insight into the evolution of Mtb-host interactions. Notably, the
West African 2 strains were distinguished by their failure to
upregulate genes required to synthesize sulfolipids (SL-1, pks2-
papA1-mmpL8) and phthiocerol dimycocerosates (PDIM, ppsABC-
DE,drrABC) within macrophage phagosomes (Supplementary
Figure S10B, S10C). The importance of SL-1 and PDIM during
infection [54], [55], [56] stem from multiple roles including cell
well integrity, modulation of the immune response, resistance of
interferon-c independent defenses, and detoxification of proprio-
nate and maintaining redox balance during lipid metabolism [55],
[56], [57], [58], [59]. Similarly, high levels of hypoxia-inducible
nitrate reductase activity, which allows nitrate respiration in the
absence of oxygen, are associated with the globally dominant
lineages of the MTC [60], [61], [62]. West African 2 isolates,
however, expressed the narGHJI nitrate reductase at depressed
levels in vitro and failed to induce both narGHJI and the nitrate/
nitrite transporter narK2X inside phagosomes (Supplementary
Figure S10A). This is consistent with clade 2-specific SNPs in the
promoters of both narGHJI and narK2X [61], [63], [64]. Although
animal studies suggest nitrate reductase is required for virulence
[65], the exact role of this virulence factor is unclear given that
nitrate reductase does not appear to support actual anaerobic
growth [66]. Thus, evolving the ability to respond to host-derived
and endogenous metabolic cues and adapt to conditions within the
host represent key steps in the continuing evolution of the MTC.
On the other hand, the Beijing genotype represents a modern
lineage whose growing predominance in the clinical setting
suggests a selective advantage over other M. tuberculosis strains.
Speculated mechanisms underlying the success of Beijing isolates
have included escape from BCG vaccination, enhanced multidrug
resistance, and expression of unique virulence lipids [67]. A recent
study by Reed et al. found that a large subset of Beijing strains
constitutively overexpress the dosRS two-component regulator and
48-gene regulon [20]. The resulting induction of a triacylglycerol
(TAG) synthase (Rv3130c) and accumulation of fatty acids in the
form of TAG was hypothesized to augment virulence by affording
a selective advantage during intracellular survival or latency. As
shown in Figure 3, the survival and intracellular replication of
Beijing isolates within murine macrophages was unremarkable
relative to other lineages, regardless of macrophage activation
state. Although our data confirmed the elevated basal transcription
levels of dosRS in Beijing isolates (Figure 2B and 6F, Supplemen-
tary Figures S8 and S9B), transcript levels of dosRS-dependent
effectors such as hspX and Rv3130c were comparable to reference
strains (CDC1551 and H37Rv). The use of microaerophilic static
growth conditions in this study, leading to moderate activation of
the DosR regulon and accumulation of TAG (data not shown)
compared to aerated growth in roller-bottles would explain the
discrepancy with the findings of Reed et al. [20], [68]. During
intracellular adaptation, the induction and overall expression of
dosRS and downstream genes was lower in Beijing strains likely as a
consequence of genotype-specific frameshift mutations in dosT
[68], encoding a histidine kinase that acts on DosR [69], [70]. Our
findings do not support the hypothesis that overexpression of dosRS
by Beijing strains provides a selective advantage for survival within
macrophages. The molecular mechanisms behind the success of
this lineage remain to be elucidated.
The global predominance of strains belonging to ‘‘modern’’
clade 1 compared to ‘‘ancestral’’ clade 2 lineages would support
the hypothesis that transcriptome features associated with these
strains represent strategies evolved for enhanced human infection
and transmission. Recent evidence suggests that a strong and
stable association exists between MTC strains and distinct
geographic regions and human populations [71], [72], [73]. Thus,
selective pressures unique to their ‘‘native’’ host environment may
be driving the genetic divergence of MTC strains.
Finally, the global resurgence of tuberculosis necessitates a
concerted effort to improve the outdated and inadequate strategies
of prevention, detection, and treatment that are currently
available. Characterization of the molecular and phenotypic
differences and similarities between clinical isolates targeted by
such interventions is a crucial component in the design of new
control measures. In fact, mathematical modeling analyses by
Cohen et al. [74] predicted that a failure to consider mycobacterial
strain diversity could have a significant negative impact on vaccine
efficacy, due to strain replacement by MTC variants not targeted
by the vaccine. The functional genetic diversity and distinct
macrophage interactions evident in our panel of strains reinforces
the need to include challenges with diverse MTC strains as a
routine step in vaccine testing [74] and drug screening.
Materials and Methods
Bacterial and cell culture
Fifteen well-characterized clinical isolates of the M. tuberculosis
complex (MTC) representing five different phylogenetic geno-
types, were selected based on previous studies on the genetic
operon, implicated in anaerobic nitrate respiration [84] and required for tissue-specific persistence in animal models [65], [85], is expressed at lower
levels in all clade 2 versus clade 1 strains. The mce4 operon, encoding a cholesterol import system required for growth in activated macrophages and
persistence in mouse lungs [30], is overexpressed in clade 2 strains. (B–D) Reduced expression of sulfolipid (SL), diacyltrehalose (DAT), and
polyacyltrehalose (PAT) synthesis genes in intracellular M. africanum West African 2 strains (B) due to lower in vitro expression (B) coupled with lower
induction (mmpL8, mmpL10, papA1) or repression (pks4, papA3, pks3) in phagosomes of resting macrophage (C). (E–G) Expression and regulation of
DosRS dormancy regulon in MTC clinical isolates. Despite in vitro overexpression of the dosRS two-component regulator in Beijing strains, transcripts
of downstream effectors were not notably elevated (E). dosRS and effectors were induced in all strains by phagosomal cues in resting (F) and
activated macrophages (data not shown). Although ‘‘absolute’’ levels of dosRS are highest in Beijing strains, DosR-dependent genes are expressed
more highly in Haarlem strains (G). Black box in genotype legend denotes reference strain CDC1551. A wider scale for gene expression (0.1–10) was
used for (A,D,G).
doi:10.1371/journal.ppat.1000988.g006
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genotyping methods and susceptibility testing as described
elsewhere (Supplementary Figure S1, Supplemental Table S1)
[2]. Two fully sequenced reference M. tuberculosis strains, H37Rv
and CDC1551, and all clinical isolates were routinely cultured in
7H9-OADC medium in 25-cm
2 vented flasks without shaking.
The MTC clinical isolates used in this study were handled to
minimize in vitro passaging. Briefly, strains were initially cultured
from clinical samples on Lowenstein-Jensen (LJ) medium for
routine diagnostic testing at the National Reference Center in
Borstel, Germany. Clinical isolate cultures used in this study were
derived from frozen stocks prepared after a single in vitro passage of
original archived samples. The clinical isolate reference strain
CDC1551 was also maintained to minimize serial passaging. The
virulent lab strain H37Rv, however, has undergone countless
rounds of in vitro passaging. For in vitro growth assays, the OD600
(BioRad Smart Spec 3000) of 15ml cultures inoculated at OD600
,0.05 from frozen stocks grown to mid-log phase was monitored.
Bone marrow-derived macrophages (MØ) were isolated from
C57BL/6 mice and grown in DMEM supplemented with 10%
FCS, 1% sodium pyruvate, 1% L- glutamine, 20% L cell-
conditioned medium and 1% penicillin and streptomycin. Media
lacking antibiotics was added at least 24h before initiation of
mycobacterial infections and maintained during infection.
Macrophage survival assays
To monitor the survival/growth of MTC strains in macro-
phages, confluent macrophage monolayers (,5610
5 cells) in 24-
well dishes were infected at an MOI ,1:1. At 0, 2, 4, 7, and 11
days post-infection, intracellular MTC were released from
monolayers by lysis with ddH2O+0.05% Tween-80, serially
diluted in PBS+0.05% Tween-80, and plated on 7H10 +
cycloheximide (10mg/ml) agar. Colony forming units were
enumerated after ,3–4 weeks incubation at 37uC. Activated
macrophages were primed with 100 units/ml of recombinant
mouse interferon-c (Peprotech) for 24h followed by pre-activation
with 10ng/ml of LPS (Sigma) for 16hr. The integrity of the
monolayer was confirmed at each time point by visual microscopic
inspection. A total of 6 wells/strain were analyzed (two
independent biological replicates with three wells/strain in each
assay).
Macrophage infections and RNA isolation
The protocol for RNA isolation from intracellular MTC has
been previously described [22]. Briefly, confluent monolayers of
,2610
7 MØ in 75-cm
2 vented tissue culture flasks were infected
(MOI ,4:1) with MTC strains grown to mid-log phase
(OD=0.6–0.8) in standing 75-cm
2 vented flasks. Control samples
consisted of an aliquot of the same bacterial preparation used to
infect macrophages that was instead placed in a 75- cm
2 flask with
no macrophages. Care was taken to treat control bacteria
identically with the exception of the condition being tested to
minimize detection of spurious changes in gene expression due to
irrelevant stimuli. Prior to infections, bacteria were declumped by
10 passages through a 21 gauge needle in PBS + 0.01% Tween-80
and diluted in 1ml of uptake buffer (PBS with 4.5mg/ml glucose,
5mg/ml defatted BSA, and 1mg/ml gelatin) and 5ml binding
medium (DMEM with 5% fetal calf serum, 10mM HEPES,
pH 7.4). After 4h infection, extracellular bacteria were removed
and replaced with fresh macrophage medium without antibiotics.
At 24h post-infection, addition of GTC lysis buffer (4M guanidine
thiocyanate, 0.5% Na N-lauryl sarcosine, 25mM sodium citrate,
and 0.1M b-mercaptoethanol) selectively lysed MØ, halted RNA
transcription/degradation while leaving mycobacteria intact as
previously described [75], [76]. Extracellular controls remained in
macrophage medium for the same 24h time course before being
stopped by the addition of GTC lysis buffer. RNA from
intracellular MTC strains and extracellular controls was isolated
and linearly amplified (using 250ng total RNA template per
reaction) as described previously [22]. Intracellular transcriptome
profiling was conducted on two independent biological replicates
for each strain in each macrophage type.
For in vitro array analyses, log-phase mycobacteria in starter
cultures grown to mid-log from frozen stocks were inoculated into
7H9-OADC medium in 25-cm
2 vented flasks at an OD ,0.05
and grown without shaking for ,1 week to an OD,0.5–0.6. As
described above, GTC lysis buffer added at a 5:1 ratio to culture
aliquots served to preserve RNA transcripts for RNA isolation and
amplification. The results presented represent the average of three
independent biological replicates.
Target preparation and microarray hybridization
Amino-allyl modified amplified RNA (aRNA) were labeled with
Alexa Fluor 555 (extracellular controls) and Alexa Fluor 647
(intracellular) (Invitrogen) and purified using a MegaClear kit
(Ambion). 10mg of Alexa-labeled aRNA from paired samples was
dried using a Speedvac and resuspended in 75ml of hybridization
buffer (56 SSC, 25% formamide, 0.1% SDS, and 25mg salmon
sperm DNA). Samples were denatured at 95uC for 5min and
briefly cooled to 60uC before being applied to arrays under a glass
LifterSlip (Erie Scientific). Slides were prehybridized for 1h in 25%
formamide, 56SSC, 0.1% SDS, 1% BSA and washed with H2O
and isopropanol. Labeled targets were hybridized to microarrays
in humidified slide chambers (Corning) at 45uC for 16–18 h.
Arrays were washed sequentially with buffer 1 (26 SSC, 0.1%
SDS) pre-warmed to 45uC, buffer 2 (0.26SSC, 0.1% SDS), buffer
3 (0.26SSC), and buffer 4 (0.056SSC). Slides were briefly dipped
in de-ionized ultrafiltered water before being dried by centrifuga-
tion (7006g, 10min).
For in vitro arrays, aRNA from clinical isolates was labeled with
Alexa 647 while aRNA from log-phase strain CDC1551 labeled
with Alexa 555 served as a common denominator on all slides. For
macrophage infection arrays, the intracellular transcriptome of
each strain was compared to a matched sample of the same strain
from a macrophage-free control to measure relative changes in
gene expression in response to the phagosome environment.
Microarray fabrication
The microarray platform used can be accessed via NCBI’s Gene
Expression Omnibu (GEO) database [77] under platform
accession number GPL5754.
Microarray data analysis
Microarrays were scanned with a GenePix 4000B instrument
(Axon Instruments, Inc.) with preliminary image analysis, spot
intensity determination, background measurements, spot quality
assessment and flagging conducted using Imagene software
(version 6.0, Biodiscovery). Poor quality spots with signal
intensities less than three standard deviations above background
were excluded from further analysis. Subsequent normalization,
statistical analysis, and visualization of array data were performed
with Genespring 7.3 (Agilent). Genes with significant changes in
expression levels relative to controls were identified based on fold
change (1.5-fold) and reproducibility between replicates (p-value
,0.05). One-way ANOVA and Tukey post-hoc tests were used to
identify genes with significant differences in expression between
conditions. For most analyses, multiple testing corrections
(Benjamini and Hochberg false discovery rate ,0.01) were
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(see Figure 6), instead of comparing with cohybridized extracel-
lular control samples, preprocessed images from the channel
representing intracellular samples were loaded into Genespring as
a single-color experiment. Per chip (normalized to 50
th percentile)
and per gene (normalized to median) normalizations were
conducted on the assembled datasets. The same approach was
employed to directly compare transcriptomes of strains from
extracellular macrophage-free controls. A high correlation be-
tween the relative transcript levels of constitutive housekeeping
genes (i.e. sigA) across the panel of clinical isolates analyzed in this
manner served to validate this approach. The relative abundance
of select transcripts expressed by intracellular MTC was further
confirmed by qRT-PCR (Supplementary Figure S10).
All microarray data has been deposited in the GEO database
under the accession number GSE21114 and is also available
through the TBDB database at www.tbdb.org [78].
Quantitative real-time RT-PCR (qRT-PCR)
RNA amplification and microarray methodology used herein
were previously validated by qRT-PCR of select genes differen-
tially regulated by the reference strain CDC1551 during infection
of bone marrow derived macrophages [22]. Additional qRT-PCR
validation of target gene expression of clinical isolates in this study
was conducted by two-step real-time RT-PCR using iScript and
iTaq SYBR Green reagents (Biorad). Each sample was analyzed in
triplicate on an ABI 7500 starting with 100ng of total RNA
(amplified and unamplified). CT values were normalized to values
obtained for sigA, a constitutively expressed Mtb gene, and relative
changes in gene expression were calculated using the 2
2DDCT
method [79].
The faithful representation of transcript levels following linear
amplification was further validated in this study by qRT-PCR of
select genes by comparing expression ratios derived from
unamplified versus amplified RNA templates prepared from
clinical isolates (Supplementary Figure S8). For qRT-PCR analysis
of in vitro and intracellular gene expression, aRNA from a single
representative strain from each genotype served as template –
Haarlem (4130/02), Beijing (12594/02), Uganda (2333/99), EAI
(4850/03), and West African 2 (10514/01).
Statistical analysis
Preliminary analysis of in vitro growth data and intramacrophage
survival/growth data was performed using GraphPad Prism
software (version 4). Statistical analysis of growth data shown in
Figure 3 and Supplemental Figure S2 were conducted using JMP
8.0 software (SAS) with assistance provided by the Cornell
Statistical Consulting Unit (CSCU). Significant differences
(p,0.05) were determined by one-way ANOVA with pair-wise
comparisons between strains made using the Tukey-Kramer HSD
post-hoc test.
Supporting Information
Figure S1 Molecular genotyping analysis of MTC clinical
isolates in this study, including 24-loci MIRU-VNTR (Mycobac-
terial Intespersed Repetitive Units-Variable Number of Tandem
Repeats), IS6110 RFLP (Restriction Fragment Length Polymor-
phism), and spoligotyping (spacer oligonucleotide typing). Note the
distinction of clade 1 strains (including Uganda, Beijing, and
Haarlem genotypes and reference strains H37Rv and CDC1551)
from clade 2 strains (EAI and West African 2 genotypes). More
complete description of mycobacterial strains can be obtained
from http://www.miru-vntrplus.org/.
Found at: doi:10.1371/journal.ppat.1000988.s001 (0.40 MB TIF)
Figure S2 In vitro growth kinetics of MTC clinical isolates. The
growth of mycobacterial strains was monitored for 20 days by
optical density (OD600) measurements of 15ml standing cultures in
7H9 liquid medium. Growth of M. tuberculosis Haarlem (A),
Uganda (B), Beijing (C), EAI (D), and M. africanum West African 2
(E) strains are shown relative to reference strains H37Rv and
CDC1551 (green lines). Colors for each genotype correspond to
colors used in Fig. 1A phylogenetic tree and throughout the
manuscript.
Found at: doi:10.1371/journal.ppat.1000988.s002 (3.52 MB TIF)
Figure S3 Condition tree of genes with clade-specific expression
profiles in vitro. One-way ANOVA (using Benjamini and Hochberg
False Discovery Rate p,0.01) of in vitro transcriptome data from
log phase bacteria identified 156 genes with significant differences
in basal expression levels between clade 1 and clade 2 strains. The
condition tree (Pearson correlation) generated from this gene list
clearly delineates strains at the clade and genotype level based on
differential transcription patterns (indicated by coloring of
branches and key shown below the tree). Expression data for
individual genes was clustered (vertical order) using the distance
measure.
Found at: doi:10.1371/journal.ppat.1000988.s003 (0.59 MB TIF)
Figure S4 Genes with strain specific in vitro transcription
patterns. Raw data were derived from array analysis of 16 MTC
strains relative to CDC1551 reference strain in log phase growth
in 7H9 medium (3 biological replicates each). One-way ANOVA
of a quality-filtered gene list (genes flagged present in 42 of 48
samples) using Benjamini and Hochberg False Discovery Rate
p,0.01 identified 195 genes with strain-specific expression. The
matrix shows the results of pair-wise comparisons between strains
using the Tukey post hoc test. The numbers within red squares
indicate genes with unique expression patterns between the two
intersecting genotypes.
Found at: doi:10.1371/journal.ppat.1000988.s004 (1.71 MB TIF)
Figure S5 Genes displaying conserved induction (A) or repres-
sion (B) in both resting and activated macrophage phagosomes
(24h post-infection) across our panel of MTC clinical isolates. Raw
data were derived from array analysis of 17 MTC strains
comparing intracellular transcript levels to extracellular controls
of the same strain. ‘‘Universal’’ genes were selected as detailed in
Figure 4 legend, with a subset of genes shown here. Genotypes are
indicated by the color bar at bottom, which corresponds to color
code shown in Figure 1A. Black indicated CDC1551 and green
indicates H37Rv. Samples from both resting (white) and activated
(gray) macrophage were included. (A) Universally induced genes
included members of the DosR dormancy regulon (Rv2032,
Rv2626c, Rv3130c, Rv1738, hspX, Rv3133c, Rv2028c), pH stimulon
(lipF), ROI stress response (furA, fdxD, Rv1460-1461, fdxA), general
stress (dnaJ, hspR, dnaK, grpE, groEL2, hsp), regulation (whiB7, furA,
sigB, whiB6 (Rv3862c)), and lipid metabolism (mez, icl, fadD9). (B)
Universally repressed genes included Type I NADH dehydroge-
nase (nuo), ATP synthase (atp), mycolic acid synthesis (acpM, fabD,
kasA, transcriptional regulators (i.e. cspA, sigD, Rv3676), putative
lipid transporters mce1 (Rv0167, Rv0171, Rv0172), mce4 (Rv3492c,
Rv3493c, Rv3497c), mmpL9, mmpS2, mmpL12, and numerous
lipoproteins (lppL, lpqM, lprO, lprJ, lprE, lprL, lprK).
Found at: doi:10.1371/journal.ppat.1000988.s005 (1.96 MB TIF)
Figure S6 Direct comparison of transcript levels from intracel-
lular MTC isolates after 24h infection of resting macrophages.
Microarray images were loaded into Genespring as a single color
experiment and normalized against the median. This effectively
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intracellular changes in gene expression. Condition tree (Spear-
man correlation) of clinical isolates based on 499 genes determined
by one-way ANOVA to exhibit genotype-dependent profiles (using
Benjamini and Hochberg False Discovery Rate p,0.01). Com-
pare with phylogenetic tree (Fig. 1A) and note clustering of strains
according to genotype and delineation of clade 1 and clade 2
strains based on ‘‘absolute’’ intracellular gene expression.
Found at: doi:10.1371/journal.ppat.1000988.s006 (0.80 MB TIF)
Figure S7 MTC clinical isolates display significantly different
growth and survival profiles in vitro and in murine macrophages.
The results of ANOVA and pair-wise comparisons between strains
using the Tukey-Kramer HSD are summarized in connecting
letter reports. Strains that do not share a letter (A–G in growth
profile column) are significantly different (p,0.05). In A), for
example, 2169/99 is significantly different from all other strains
whereas 4130/02 is similar to 2336/02 and 2333/99. Strains are
ranked from top to bottom by least-squares differences means
which correlates with the growth/fitness of strains in vitro (A), in
resting macrophages (B), or activated macrophages (C). Strain
names are color coded to indicate genotype (red=Haarlem,
blue=Beijing, orange=Uganda, purple=EAI, brown=West
African 2). Clinical isolates belonging to clade 1 are shown with
a white background while clade 2 isolates are highlighted in gray.
Found at: doi:10.1371/journal.ppat.1000988.s007 (1.88 MB TIF)
Figure S8 Validation of linear RNA amplification by qRT-
PCR. Unamplified and amplified RNA from log phase in vitro
mycobacteria including CDC1551 (reference strain), Beijing strain
12594/02, and EAI strain 4850/03 was reverse transcribed and
quantified by relative qRT-PCR by normalization to sigA.
Expression ratios shown are relative to the reference strain
CDC1551. Solid bars and open bars represent the use of
unamplified and amplified RNA, respectively. There was an
excellent correlation between expression ratios derived from
amplified and unamplified RNA. Note the overexpression of the
dosR two-component response regulator in the Beijing strain.
Although the dosR-dependent gene Rv3130c is expressed higher in
Beijing versus EAI, transcript levels are comparable between
12594/02 and the reference strain, CDC1551. The overexpres-
sion of virS and concomitant repression of Rv3083 in EAI versus
Beijing and CDC1551 verifies the genotype-specific regulation of
this operon. Error bars indicate the standard deviation of DDCT
values calculated as described in the Guide to Performing Relative
Quantitation of Gene Expression Using Real-Time Quantitative
PCR (ABI).
Found at: doi:10.1371/journal.ppat.1000988.s008 (0.35 MB TIF)
Figure S9 qRT-PCR analysis of select mycobacterial virulence
factors exhibiting strain-dependent expression profiles in vitro.A )
Overexpression of mce4C (involved in cholesterol uptake and
metabolism) in West African 2 and EAI (clade 2 strains). B) Beijing
genotype specific overexpression of dosR (response regulator of the
hypoxia/dormancy regulon) but not dosR-dependent effectors
(hspX, Rv3130c). C) EAI genotype specific overexpression of virS
transcriptional regulator and repression of virS-dependent Rv3083.
The color legend shown in A), which corresponds to colors used in
all figures to designate specific genotypes, was also applied in B)
and C). See legend for Supplementary Figure S8 for description of
error bars.
Found at: doi:10.1371/journal.ppat.1000988.s009 (0.70 MB TIF)
Figure S10 qRT-PCR analysis of select mycobacterial virulence
factors exhibiting strain-dependent expression profiles during
intracellular growth within macrophages. Data labeled ‘‘Outside’’
at the left of each panel represents the direct comparison (as
detailed in Materials and Methods) of transcript levels in
macrophage-controls incubated in DMEM infection medium for
24hr at 37C. Similarly, data labeled ‘‘Inside’’ at the right of each
panel reflects direct comparison of transcript levels from
intracellular MTC 24hr post-infection. For each gene, expression
ratios ‘‘outside’’ and ‘‘inside’’ are expressed relative to West
African 2 following normalization to sigA from the same sample.
‘‘Macrophage’’ expression ratios represent changes of gene
expression upon macrophage invasion relative to levels in
extracellular, macrophage-free controls. A) The underexpression
of narG in vitro (outside) and lack of intracellular induction
(macrophage) in West African 2 strains leads to large differences
in transcript levels within the phagosome (inside). B) Differential
basal expression and intracellular induction of ppsA in West
African 2 strains. C) Elevated expression of dosR by extracellular
control Beijing strains coupled with dampened induction upon
macrophage infection results in comparable levels of dosR in the
phagosome across all genotypes. D) Intracellular transcript levels
of the dosR-dependent triacylglycerol synthase Rv3130c were
lowest in the Beijing genotype, reflecting the ,10-fold lower
induction inside macrophages. E) Reduced transcript levels of pks2,
a polyketide synthase involved in synthesis of the cell wall
component sulfolipid [32,34], by West African 2 strains is a
combined result of lower baseline expression in vitro and defective
upregulation within the phagosome. See legend for Supplemen-
tary Figure S8 for description of error bars.
Found at: doi:10.1371/journal.ppat.1000988.s010 (1.03 MB TIF)
Table S1 Clade specific gene expression in vitro (93 genes, Clade
1.Clade 2). This list was based on one-way ANOVA analysis of in
vitro transcriptome data from log phase bacteria (using Benjamini
and Hochberg False Discovery Rate p,0.01). The values indicate
expression ratios relative to the CDC1551 reference strain.
Found at: doi:10.1371/journal.ppat.1000988.s011 (0.05 MB XLS)
Table S2 Clade specific gene expression in vitro, (63 genes, Clade
2.Clade 1). This list was based on one-way ANOVA analysis of in
vitro transcriptome data from log phase bacteria (using Benjamini
and Hochberg False Discovery Rate p,0.01). The values indicate
expression ratios relative to the CDC1551 reference strain.
Found at: doi:10.1371/journal.ppat.1000988.s012 (0.04 MB XLS)
Table S3 Universally induced genes in resting and activated
macrophages. Identification of genes with conserved expression
and regulation inside macrophage phagosome across global panel
of MTC clinical isolates. Global gene expression profiles of 17
MTC strains 24h post-infection of resting and activated macro-
phages were determined by microarray. Normalized expression
ratios for each strain were determined by comparison of RNA
from intracellular bacteria versus control bacteria of the same
strain treated identically except for phagocytosis by macrophages.
‘‘Universal genes’’ were selected based on trending up or down in
all strains (up .1.2-fold in 15 of 17 strains) and significantly being
induced in .50% of strains (up .1.56in 8 of 17 strains) in each
macrophage type. The starting gene list for this analysis included
only genes flagged as present in the majority of samples from both
macrophage types. Shown are the 168 genes universally induced
in resting and activated macrophages (Figure 4a, white).
Found at: doi:10.1371/journal.ppat.1000988.s013 (0.13 MB XLS)
Table S4 Universally induced genes in resting macrophages
only. See legend for Table S3 for details of analysis parameters.
Shown are 57 genes induced by panel of MTC clinical isolates in
resting macrophages only (Figure 4a, red).
Found at: doi:10.1371/journal.ppat.1000988.s014 (0.06 MB XLS)
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only. See legend for Table S3 for details of analysis parameters.
Shown are 119 genes induced by panel of MTC clinical isolates in
activated macrophages only (Figure 4a, blue).
Found at: doi:10.1371/journal.ppat.1000988.s015 (0.10 MB XLS)
Table S6 Universally repressed genes in resting and activated
macrophages. See legend for Table S3 for details of analysis
parameters. Shown are the 112 genes repressed in panel of MTC
clinical isolates in resting and activated macrophages (Figure 4b,
white).
Found at: doi:10.1371/journal.ppat.1000988.s016 (0.10 MB XLS)
Table S7 Universally repressed genes in resting macrophages
only. See legend for Table S3 for details of analysis parameters.
Shown are the 42 genes repressed in panel of MTC clinical isolates
in resting and activated macrophages (Figure 4b, red).
Found at: doi:10.1371/journal.ppat.1000988.s017 (0.05 MB XLS)
Table S8 Universally repressed genes in activated macrophages
only. See legend for Suppl. Table S4 for details of analysis
parameters. Shown are the 152 genes repressed in panel of MTC
clinical isolates in activated macrophages only (Figure 4b, blue).
Found at: doi:10.1371/journal.ppat.1000988.s018 (0.12 MB XLS)
Table S9 Activation-dependent genes (activated.resting) iden-
tified by one-way ANOVA of all intracellular transcription profiles
(Benjamini and Hochberg False Discovery Rate p,0.01). Global
gene expression profiles of 17 MTC strains 24h post-infection of
resting and activated macrophages were determined by micro-
array. Normalized (lowess) expression ratios for each strain were
determined by comparison of RNA from intracellular bacteria
versus control bacteria of the same strain treated identically except
for phagocytosis by macrophages.
Found at: doi:10.1371/journal.ppat.1000988.s019 (0.23 MB XLS)
Table S10 Activation-dependent genes (resting.activated) iden-
tified by one-way ANOVA of all intracellular transcription profiles
(Benjamini and Hochberg False Discovery Rate p,0.01). See
legend for Suppl Table S9 for explanation of expression values.
Found at: doi:10.1371/journal.ppat.1000988.s020 (0.29 MB XLS)
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